# QoLIDia: Quality of Life in Cancer Patients With Diabetes During Immunotherapy

> **NCT07466212** · — · NOT_YET_RECRUITING · sponsor: **Odense University Hospital** · enrollment: 920 (estimated)

## Conditions studied

- Cancer
- Type 2 Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07466212
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-10
- **Primary completion:** 2027-10-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 920 (ESTIMATED)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07466212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07466212, "QoLIDia: Quality of Life in Cancer Patients With Diabetes During Immunotherapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07466212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*